Sharda Cropchem: Unaudited Financial Result (Standalone and Consolidated) for Quarter and Half Year ended 30th September, 2026
Sharda Cropchem (SHARDACROP) filed a disclosure titled "Unaudited Financial Result (Standalone and Consolidated) for Quarter and Half Year ended 30th September, 2026". The company is valued at about ₹6,164 crore.
What happened
Sharda Cropchem (SHARDACROP) filed a disclosure with the exchanges on 30 October 2026 at 01:42 PM titled "Unaudited Financial Result (Standalone and Consolidated) for Quarter and Half Year ended 30th September, 2026".
Company snapshot
Sharda Cropchem is a small-cap company in the Chemicals sector, with a market value of about ₹6,164 crore.
The stock last traded at ₹683.2, against a 52-week range of ₹622.5–₹1,297 (47.3% below the high).
Before this filing the shares had moved −8.9% over the month and −17.2% over three months. Average daily turnover over the last 20 sessions was about ₹6.64 crore.
Promoters held 74.82% at the end of Q1 FY27. Foreign institutions owned 3.11% and domestic institutions 9.18%.
| Quarter | Revenue | Net profit | EPS (₹) |
|---|---|---|---|
| Q1 FY26 | 985 | 142.8 | 15.83 |
| Q2 FY26 | 929 | 74.3 | 8.24 |
| Q3 FY26 | 1,289 | 145.1 | 16.09 |
| Q4 FY26 | 2,065 | 318.6 | 35.32 |
| Q1 FY27 | 1,074 | 88 | 9.76 |
What history shows
BCEIE's records show 2 previous results filings from the company since May 2026.
Across 203 similar disclosures by other Chemicals companies, shares moved −1.1% on average the next day and −0.7% over five days; 36% of them rose the next day.
Market-wide, 10,043 results filings with an impact score of 50 or more saw an average next-day move of −0.3%, with 42% rising.
Past reactions describe what happened before; they are not a forecast.
What to watch
- Management commentary, margins and order book or guidance in the investor presentation.
- 30 October 2026: Board meeting — Financial Results.
In the news
Recent coverage elsewhere (links open the original publisher):
Source
Automatically written from the exchange filing and BCEIE data. Not investment advice. Check the original filing before acting on it.